Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.